Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Anaemia
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Anaemia
    TopAbstracts in Anaemia 09/03/2008 - (DGNews)
    TopAbstracts in Anaemia 08/20/2008 - (DGNews)
    New Test Measures Hepcidin, Can Help Diagnose Anaemias and Iron Disorders - (DGNews)
    TopAbstracts in Anaemia 08/07/2008 - (DGNews)
    Single Lot of Epoetin Alfa Recalled Due to Damaged Vials - (DGNews)

    News archive

     Recent webcasts/CME - Anaemia
    Bridging Interdisciplinary and Resource Gaps in CKD-Anemia Management

    Webcasts/CME archive

     Recent cases - Anaemia
      Severe Hemolytic Anemia as the First Manifestation of G6PD Deficiency in a Child with Acute Hepatitis A Infection
      Rare Ileal Localisation of Angiolipoma Presenting as Chronic Haemorrhage and Severe Anaemia: A Case Report
      Severe Thrombocytosis and Anemia Associated with Celiac Disease in a Young Female Patient: A Case Report
      Paroxysmal Cold Haemoglobinuria Leading to Acute Renal Failure: A Case Report
      Pancytopenia Due to Iron Deficiency Worsened by Iron Infusion: A Case Report

      Cases archive
        




      my personal edition > anaemia > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Erythropoeitic Agents May Help Cancer Patients With Cancer-related or Chemotherapy Related Anemia: Presented at NCCN

      By Jerry Ingram

      HOLLYWOOD, FL -- March 21, 2005 -- Treatment with epoetin alfa or darbepoetin alfa may help patients who suffer from cancer- or chemotherapy-related anemia, researchers reported here on March 17th at the National Comprehensive Cancer Network 10th Annual conference.

      Seventy percent of patients with hematologic malignancies experience anemia either as a result of cancer or chemotherapy treatments, according to speaker David J. Straus, MD, attending physician, Memorial Sloan-Kettering Cancer Center, New York, New York, United States.

      Current clinical practice guidelines suggest that patients with cancer- or chemotherapy-related anemia should be treated with epoetins -- epoetin alfa and darbepoetin alfa -- Dr. Straus reported. However, he pointed out, 47% of patients with hematologic malignancies actually receive treatment for anemia and when they do, treatment is administered when hemoglobin levels are lower than those recommended by the American Society of Hematology/American Society of Clinical Oncology.

      Citing several randomized studies, Dr. Straus emphasized the effectiveness of epoetins in treating these patients. "Epoetins significantly increased hemoglobin [levels] and improved the quality of life in patients with chemo-related anemia," he stated.

      One additional benefit is the reduction in the number of transfusions that patients are required to undergo. A review of retrospective analyses points to the benefit of early intervention since patients with improved hemoglobin usually report improvements in quality of life.

      Although Dr. Straus maintained that epoetin alfa and darbepoetin alfa benefit patients with anemia, he stressed that no data are available yet from randomized trials powered to show equivalence between the two treatments.


      [Presentation title: Comparative Studies on Erythropoeitic Agents.]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send